India’s healthcare workforce is gaining a new pathway to international careers. OET and the International Institute of Medical Sciences and Technical Council (IIMSTC) have joined forces to support this goal
Plaque psoriasis patients in India may soon have a new treatment option. Optimus Pharma has received approval from the Drug Controller General of India (DCGI). The approval covers Tapinarof Cream 1% w/w for adult patients with plaque psoriasis.
The GLP-1 boom is pushing companies across consumer industries to rethink what people eat, drink, and buy. Weight-loss drugs are creating new demand beyond the pharmaceutical sector. Companies now see opportunities in nutrition, food, beverages...
AI innovation is accelerating across India’s drug development, approvals, medical devices and specialized healthcare ecosystem
Lung cancer trial development at AstraZeneca has hit a setback. The company discontinued its Phase III eVOLVE-Lung02 study of volrustomig with chemotherapy in metastatic non-small cell lung cancer
Lupin has received a key FDA approval that strengthens its position in sleep disorder drugs. The approval covers its generic Pitolisant Tablets for the US market. The latest regulatory clearance allows Lupin to market Pitolisant Tablets in 4.45 mg...
Pharmaceutical growth in India is entering a phase where CDMOs can play a larger role in shaping manufacturing, innovation, and global market access
Telangana has brought its Food Safety Department and Drugs Control Administration under one administrative structure called the Telangana Standards Authority for Food and Essential Drugs
FDA observation outcomes at Aurobindo Pharma's Raleigh facility have moved into a new phase after the US regulator classified the site as Voluntary Action Indicated
.png "Sun Pharma Gets Major Relief in Lipitor Antitrust Litigation")
Sun Pharma has secured major relief in its long-running Antitrust litigation in the U.S. The company said a U.S. appeals court upheld a lower court ruling in its favor. The case relates to generic Lipitor and a patent settlement involving Ranbaxy...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")